The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2023

Filed:

Oct. 07, 2020
Applicant:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Inventors:

Masato Yoshikawa, Fujisawa Kanagawa, JP;

Morihisa Saitoh, Fujisawa Kanagawa, JP;

Taisuke Kato, Fujisawa Kanagawa, JP;

Yayoi Nakayama, Fujisawa Kanagawa, JP;

Tomohiro Seki, Fujisawa Kanagawa, JP;

Yasuo Nakagawa, Fujisawa Kanagawa, JP;

Yusuke Tominari, Fujisawa Kanagawa, JP;

Masaki Seto, Fujisawa Kanagawa, JP;

Yusuke Sasaki, Fujisawa Kanagawa, JP;

Masanori Okaniwa, Fujisawa Kanagawa, JP;

Tsuneo Oda, Fujisawa Kanagawa, JP;

Akito Shibuya, Fujisawa Kanagawa, JP;

Kosuke Hidaka, Fujisawa Kanagawa, JP;

Zenyu Shiokawa, Fujisawa Kanagawa, JP;

Shumpei Murata, Fujisawa Kanagawa, JP;

Atsutoshi Okabe, Fujisawa Kanagawa, JP;

Yoshihisa Nakada, Fujisawa Kanagawa, JP;

Michiyo Mochizuki, Fujisawa Kanagawa, JP;

Brian Scott Freeze, Boston, MA (US);

Taisuke Tawaraishi, Fujisawa Kanagawa, JP;

Yasufumi Wada, Fujisawa Kanagawa, JP;

Paul D. Greenspan, Acton, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7084 (2006.01); A61P 35/00 (2006.01); C07H 21/00 (2006.01); C07H 21/02 (2006.01); A61K 47/68 (2017.01); A61K 31/7076 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7084 (2013.01); A61K 31/7076 (2013.01); A61K 47/6807 (2017.08); A61P 35/00 (2018.01); C07H 21/00 (2013.01); C07H 21/02 (2013.01);
Abstract

The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases. The present disclosure relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof.


Find Patent Forward Citations

Loading…